• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

倍他米松二丙酸酯喷雾 0.05% 可缓解斑块状银屑病的麻烦症状。

Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis.

机构信息

Henry Ford Medical Center, Detroit, Michigan, USA.

Psoriasis Treatment Center of Central New Jersey, East Windsor, USA.

出版信息

Cutis. 2020 Feb;105(2):97-102;E1.

PMID:32186532
Abstract

Patients consider pruritus and scaling to be the most bothersome symptoms of psoriasis. Psoriatic plaques on the knees and elbows are widely considered difficult to treat because of the thicker stratum corneum, which reduces skin hydration and topical absorption. Betamethasone dipropionate (BD) spray 0.05% is a topical steroid with demonstrated efficacy in treating plaque psoriasis. Post hoc analyses of 2 phase 3 trials were done to assess the efficacy of BD spray in relieving the symptom of itching and improving the signs of erythema, scaling, and plaque elevation on plaques located on the knees and elbows vs its vehicle and an augmented BD (AugBD) lotion 0.05%. Betamethasone dipropionate spray reduced the incidence of pruritus, with approximately half of patients who reported itching at baseline showing complete itch relief by day 4. Betamethasone dipropionate spray also reduced the signs of psoriasis on knee and elbow plaques in more patients than AugBD lotion at day 4, though the differences were not statistically significant. Efficacy was similar between the 2 formulations on days 8 and 15. Betamethasone dipropionate spray rapidly relieved2 of the most bothersome symptoms of psoriasis and improved psoriatic signs in hard-to-treat knee and elbow plaques.

摘要

患者认为瘙痒和鳞屑是银屑病最恼人的症状。由于角质层较厚,会降低皮肤的水分和局部吸收,因此膝关节和肘关节的银屑病斑块被广泛认为难以治疗。倍他米松二丙酸酯(BD)喷雾剂 0.05%是一种局部皮质类固醇,已被证明在治疗斑块状银屑病方面具有疗效。对 2 项 3 期临床试验进行了事后分析,以评估 BD 喷雾剂在缓解瘙痒症状和改善位于膝关节和肘关节上的斑块的红斑、鳞屑和斑块隆起的体征方面的疗效,与赋形剂和增强型 BD(AugBD)乳液 0.05%相比。BD 喷雾剂可降低瘙痒的发生率,约有一半在基线时报告瘙痒的患者在第 4 天完全缓解瘙痒。与 AugBD 乳液相比,BD 喷雾剂在第 4 天也能使更多的患者膝关节和肘关节斑块上的银屑病症状得到改善,尽管差异无统计学意义。在第 8 天和第 15 天,两种制剂的疗效相似。BD 喷雾剂迅速缓解了银屑病最恼人的两种症状,并改善了治疗困难的膝关节和肘关节斑块的银屑病体征。

相似文献

1
Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis.倍他米松二丙酸酯喷雾 0.05% 可缓解斑块状银屑病的麻烦症状。
Cutis. 2020 Feb;105(2):97-102;E1.
2
DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis.DFD-01,一种新型的中效0.05%丙酸倍他米松润肤喷雾,在治疗中度斑块状银屑病方面显示出与强化型0.05%丙酸倍他米松洗剂相似的疗效。
J Drugs Dermatol. 2016 Feb;15(2):154-62.
3
Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.中重度头皮银屑病患者中,每日两次倍他米松二丙酸酯增强型洗剂与丙酸氯倍他索溶液的疗效及安全性比较
Clin Ther. 1995 May-Jun;17(3):390-401. doi: 10.1016/0149-2918(95)80104-9.
4
DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis.DFD - 01:一种用于治疗广泛性银屑病的新型二丙酸倍他米松局部制剂。
Expert Rev Clin Immunol. 2017 Feb;13(2):85-91. doi: 10.1080/1744666X.2017.1270756. Epub 2016 Dec 21.
5
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.他扎罗汀倍他米松乳膏治疗斑块状银屑病患者的疗效:一项前瞻性、多中心、观察性研究的结果。
Dermatology. 2021;237(4):603-610. doi: 10.1159/000511891. Epub 2020 Dec 22.
6
Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.在局部银屑病治疗中,骨化三醇的治疗效果持续性优于二丙酸倍他米松。
J Dermatolog Treat. 2003 Jan;14(1):8-13. doi: 10.1080/09546630305545.
7
Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.银屑病与皮肤疼痛:卡泊三醇倍他米松双丙酸酯气雾泡沫剂的真实疗效。
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1312-1315. doi: 10.1111/jdv.15488. Epub 2019 Mar 7.
8
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.与倍他米松 17-戊酸酯贴剂相比,卡泊三醇倍他米松二丙酸酯气雾剂泡沫治疗银屑病的疗效和安全性
Clin Drug Investig. 2017 Apr;37(4):355-361. doi: 10.1007/s40261-016-0489-5.
9
A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.一项比较研究,旨在评估使用卡泊三醇/倍他米松外用混悬液与0.05%丙酸倍他米松洗剂治疗的银屑病患者的表皮屏障完整性。
J Drugs Dermatol. 2017 Aug 1;16(8):747-752.
10
Efficacy, Safety, and Potency of Betamethasone Dipropionate Spray 0.05%: A Treatment for Adults with Mild-to-moderate Plaque Psoriasis.0.05%丙酸倍他米松喷雾剂治疗成人轻至中度斑块状银屑病的疗效、安全性及效能
J Clin Aesthet Dermatol. 2018 Apr;11(4):14-22. Epub 2018 Apr 1.

引用本文的文献

1
Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment.卡泊三醇/倍他米松二丙酸酯不同剂型治疗银屑病的疗效与安全性:凝胶剂、泡沫剂和软膏剂
J Clin Med. 2021 Nov 28;10(23):5589. doi: 10.3390/jcm10235589.